STERILE AQUEOUS PHARMACEUTICAL COMPOSITION BASED ON LAZAROID OR ITS PHARMACEUTICALLY ACCEPTABLE SALT FOR PARENTERAL ADMINISTRATION Russian patent published in 2000 - IPC

FIELD: pharmacy. SUBSTANCE: sterile aqueous parenteral pharmaceutical composition has one or more lazaroids or pharmaceutically acceptable salts, citrate (buffer), cosolvent and water. Used pharmaceutically acceptable acid-additive salts involves hydrochlorides, hydrobromides, hydroiodides, sulfates, phosphates, methanesulfonates, maleates. fumarates and oxalates but mesylate (monomethanesulfonate) salts are preferable. The necessary amount of lazaroid is from 0.9 to 90 mg/ml. Compositions can be used for treatment and/or prophylaxis of degenerative neurological disorders. EFFECT: realization of proposed prescription. 16 cl, 4 ex